Lo.G protects medicines in transit
LIVE FROM TOTAL PROCESS & PACKAGING
The Lo.G protects products in transit with the help of a patented 360° impact absorbing buffer system, which ensures that contents are centrally cushioned and protected.
Lo.G packs are made from recycled HDPE plastic. As a nesting product, they offer weight, space and energy savings throughout the supply chain, from warehousing to point-of-sale, when compared with EPS block or foam protective packaging.
Plastique of Tunbridge Wells, Kent offers the Lo.G packaging in single piece ‘wrap-round and lock’ boxes or end cap formats to suit a variety of products.
The company also unveiled Paperlite rPET material developed by Flextrus of Sweden, which is an alternative to thermoformed plastic trays.
According to Plastique’s sales and marketing executive, Daryl Thompson, PaperLite can be used for packaging drugs or medical devices. The material, which looks and feels like paper, is based on FibreForm from Billerud and will run on existing form fill and seal lines. It is also FSC certified and has environmental advantages over thermoformed plastic trays.
PaperLite won the Packaging Innovation Award 2009 at the Scanpack exhibition in Gothenburg.
You may also like
Trending Articles
Upcoming event
You may also like
Manufacturing
Nulogy launches Supplier Compliance Management to build stronger, more resilient supplier networks
Nulogy, a leading provider of manufacturing operations software, announced the launch of Nulogy Supplier Compliance Management, a solution designed to centralise and automate supplier compliance for procurement, supply chain, and quality assurance teams in manufacturing, food & beverage, pharmaceuticals, and
other highly regulated industries
Research & Development
COVID-19 immunity lowers the risk of a new pandemic
Researchers at the MRC-University of Glasgow Centre for Virus Research have demonstrated that the likelihood of the emergence of a new SARS-type virus pandemic has been significantly reduced by population-wide immunity to SARS-CoV-2